Friday, July 25, 2014

A bloody controversy!

People with a variety of medical conditions require anti-coagulation, medications that interfere with normal blood clotting.  While the most common oral medication used has long been warfarin, commonly known by the brand name Coumadin, a new group of drugs has recently been introduced, which promise freedom from the dietary restrictions and periodic blood tests that warfarin requires.  Now, an article in the British Medical Journal discusses questions about the process that brought the first of these drugs, Pradaxa, to market.  The MedPageToday website asked for my thoughts on this situation:

Friday Feedback: Pradaxa Monitoring?

No comments:

Post a Comment